Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
6 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Alemtuzumab for patients with relapsing multiple sclerosis after disease-modifying therapy: a randomised controlled phase 3 trial.
Lancet. 2012 Nov 24;380(9856):1829-39. doi: 10.1016/S0140-6736(12)61768-1. Epub 2012 Nov 1.
Lancet. 2012.
PMID: 23122650
Clinical Trial.
Alemtuzumab vs. interferon beta-1a in early multiple sclerosis.
CAMMS223 Trial Investigators; Coles AJ, Compston DA, Selmaj KW, Lake SL, Moran S, Margolin DH, Norris K, Tandon PK.
CAMMS223 Trial Investigators, et al.
N Engl J Med. 2008 Oct 23;359(17):1786-801. doi: 10.1056/NEJMoa0802670.
N Engl J Med. 2008.
PMID: 18946064
Free article.
Clinical Trial.
Item in Clipboard
B cell depletion with ublituximab reshapes the T cell profile in multiple sclerosis patients.
Lovett-Racke AE, Gormley M, Liu Y, Yang Y, Graham C, Wray S, Racke MK, Shubin R, Twyman C, Alvarez E, Bass A, Eubanks JL, Fox E.
Lovett-Racke AE, et al.
J Neuroimmunol. 2019 Jul 15;332:187-197. doi: 10.1016/j.jneuroim.2019.04.017. Epub 2019 May 3.
J Neuroimmunol. 2019.
PMID: 31077854
Free article.
Item in Clipboard
Two phase 3 trials of bapineuzumab in mild-to-moderate Alzheimer's disease.
Salloway S, Sperling R, Fox NC, Blennow K, Klunk W, Raskind M, Sabbagh M, Honig LS, Porsteinsson AP, Ferris S, Reichert M, Ketter N, Nejadnik B, Guenzler V, Miloslavsky M, Wang D, Lu Y, Lull J, Tudor IC, Liu E, Grundman M, Yuen E, Black R, Brashear HR; Bapineuzumab 301 and 302 Clinical Trial Investigators.
Salloway S, et al.
N Engl J Med. 2014 Jan 23;370(4):322-33. doi: 10.1056/NEJMoa1304839.
N Engl J Med. 2014.
PMID: 24450891
Free PMC article.
Clinical Trial.
Item in Clipboard
A giant MS plaque mimicking PML during natalizumab treatment.
Twyman C, Berger JR.
Twyman C, et al.
J Neurol Sci. 2010 Apr 15;291(1-2):110-3. doi: 10.1016/j.jns.2010.01.001. Epub 2010 Feb 7.
J Neurol Sci. 2010.
PMID: 20144466
Item in Clipboard
Alemtuzumab improves preexisting disability in active relapsing-remitting MS patients.
Giovannoni G, Cohen JA, Coles AJ, Hartung HP, Havrdova E, Selmaj KW, Margolin DH, Lake SL, Kaup SM, Panzara MA, Compston DA; CARE-MS II Investigators.
Giovannoni G, et al.
Neurology. 2016 Nov 8;87(19):1985-1992. doi: 10.1212/WNL.0000000000003319. Epub 2016 Oct 12.
Neurology. 2016.
PMID: 27733571
Free PMC article.
Clinical Trial.
Item in Clipboard
Cite
Cite